##fileformat=VCFv4.1,VCFv4.2
##source=freeBayes v1.0.2-29-g41c1313,freeBayes v1.3.1-17-gaa2ace8
##sequence_region="chr17 7651483 7704425"
##reference=/export-data/public/repository/GRCh38NoPatch.fa
##phasing=none
##fileDate=20220321
##contig=<ID=chrY,length=57227415>
##contig=<ID=chrX,length=156040895>
##contig=<ID=chrM,length=16569>
##contig=<ID=chr9,length=138394717>
##contig=<ID=chr8,length=145138636>
##contig=<ID=chr7,length=159345973>
##contig=<ID=chr6,length=170805979>
##contig=<ID=chr5,length=181538259>
##contig=<ID=chr4,length=190214555>
##contig=<ID=chr3,length=198295559>
##contig=<ID=chr22,length=50818468>
##contig=<ID=chr21,length=46709983>
##contig=<ID=chr20,length=64444167>
##contig=<ID=chr2,length=242193529>
##contig=<ID=chr19,length=58617616>
##contig=<ID=chr18,length=80373285>
##contig=<ID=chr17,length=83257441>
##contig=<ID=chr16,length=90338345>
##contig=<ID=chr15,length=101991189>
##contig=<ID=chr14,length=107043718>
##contig=<ID=chr13,length=114364328>
##contig=<ID=chr12,length=133275309>
##contig=<ID=chr11,length=135086622>
##contig=<ID=chr10,length=133797422>
##contig=<ID=chr1,length=248956422>
##commandline="freebayes -f /export-data/public/repository/GRCh38NoPatch.fa -L ./bams.txt -s ./samples.txt --region chr1:10005-5746528"
##INFO=<ID=NS,Number=1,Type=Integer,Description="Number of samples with data">
##INFO=<ID=DP,Number=1,Type=Integer,Description="Total read depth at the locus">
##INFO=<ID=DPB,Number=1,Type=Float,Description="Total read depth per bp at the locus; bases in reads overlapping / bases in haplotype">
##INFO=<ID=AC,Number=A,Type=Integer,Description="Total number of alternate alleles in called genotypes">
##INFO=<ID=AN,Number=1,Type=Integer,Description="Total number of alleles in called genotypes">
##INFO=<ID=AF,Number=A,Type=Float,Description="Estimated allele frequency in the range (0,1]">
##INFO=<ID=RO,Number=1,Type=Integer,Description="Count of full observations of the reference haplotype.">
##INFO=<ID=AO,Number=A,Type=Integer,Description="Count of full observations of this alternate haplotype.">
##INFO=<ID=PRO,Number=1,Type=Float,Description="Reference allele observation count, with partial observations recorded fractionally">
##INFO=<ID=PAO,Number=A,Type=Float,Description="Alternate allele observations, with partial observations recorded fractionally">
##INFO=<ID=QR,Number=1,Type=Integer,Description="Reference allele quality sum in phred">
##INFO=<ID=QA,Number=A,Type=Integer,Description="Alternate allele quality sum in phred">
##INFO=<ID=PQR,Number=1,Type=Float,Description="Reference allele quality sum in phred for partial observations">
##INFO=<ID=PQA,Number=A,Type=Float,Description="Alternate allele quality sum in phred for partial observations">
##INFO=<ID=SRF,Number=1,Type=Integer,Description="Number of reference observations on the forward strand">
##INFO=<ID=SRR,Number=1,Type=Integer,Description="Number of reference observations on the reverse strand">
##INFO=<ID=SAF,Number=A,Type=Integer,Description="Number of alternate observations on the forward strand">
##INFO=<ID=SAR,Number=A,Type=Integer,Description="Number of alternate observations on the reverse strand">
##INFO=<ID=SRP,Number=1,Type=Float,Description="Strand balance probability for the reference allele: Phred-scaled upper-bounds estimate of the probability of observing the deviation between SRF and SRR given E(SRF/SRR) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=SAP,Number=A,Type=Float,Description="Strand balance probability for the alternate allele: Phred-scaled upper-bounds estimate of the probability of observing the deviation between SAF and SAR given E(SAF/SAR) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=AB,Number=A,Type=Float,Description="Allele balance at heterozygous sites: a number between 0 and 1 representing the ratio of reads showing the reference allele to all reads, considering only reads from individuals called as heterozygous">
##INFO=<ID=ABP,Number=A,Type=Float,Description="Allele balance probability at heterozygous sites: Phred-scaled upper-bounds estimate of the probability of observing the deviation between ABR and ABA given E(ABR/ABA) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=RUN,Number=A,Type=Integer,Description="Run length: the number of consecutive repeats of the alternate allele in the reference genome">
##INFO=<ID=RPP,Number=A,Type=Float,Description="Read Placement Probability: Phred-scaled upper-bounds estimate of the probability of observing the deviation between RPL and RPR given E(RPL/RPR) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=RPPR,Number=1,Type=Float,Description="Read Placement Probability for reference observations: Phred-scaled upper-bounds estimate of the probability of observing the deviation between RPL and RPR given E(RPL/RPR) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=RPL,Number=A,Type=Float,Description="Reads Placed Left: number of reads supporting the alternate balanced to the left (5') of the alternate allele">
##INFO=<ID=RPR,Number=A,Type=Float,Description="Reads Placed Right: number of reads supporting the alternate balanced to the right (3') of the alternate allele">
##INFO=<ID=EPP,Number=A,Type=Float,Description="End Placement Probability: Phred-scaled upper-bounds estimate of the probability of observing the deviation between EL and ER given E(EL/ER) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=EPPR,Number=1,Type=Float,Description="End Placement Probability for reference observations: Phred-scaled upper-bounds estimate of the probability of observing the deviation between EL and ER given E(EL/ER) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=DPRA,Number=A,Type=Float,Description="Alternate allele depth ratio.  Ratio between depth in samples with each called alternate allele and those without.">
##INFO=<ID=ODDS,Number=1,Type=Float,Description="The log odds ratio of the best genotype combination to the second-best.">
##INFO=<ID=GTI,Number=1,Type=Integer,Description="Number of genotyping iterations required to reach convergence or bailout.">
##INFO=<ID=TYPE,Number=A,Type=String,Description="The type of allele, either snp, mnp, ins, del, or complex.">
##INFO=<ID=CIGAR,Number=A,Type=String,Description="The extended CIGAR representation of each alternate allele, with the exception that '=' is replaced by 'M' to ease VCF parsing.  Note that INDEL alleles do not have the first matched base (which is provided by default, per the spec) referred to by the CIGAR.">
##INFO=<ID=NUMALT,Number=1,Type=Integer,Description="Number of unique non-reference alleles in called genotypes at this position.">
##INFO=<ID=MEANALT,Number=A,Type=Float,Description="Mean number of unique non-reference allele observations per sample with the corresponding alternate alleles.">
##INFO=<ID=LEN,Number=A,Type=Integer,Description="allele length">
##INFO=<ID=MQM,Number=A,Type=Float,Description="Mean mapping quality of observed alternate alleles">
##INFO=<ID=MQMR,Number=1,Type=Float,Description="Mean mapping quality of observed reference alleles">
##INFO=<ID=PAIRED,Number=A,Type=Float,Description="Proportion of observed alternate alleles which are supported by properly paired read fragments">
##INFO=<ID=PAIREDR,Number=1,Type=Float,Description="Proportion of observed reference alleles which are supported by properly paired read fragments">
##INFO=<ID=MIN_DP,Number=1,Type=Integer,Description="Minimum depth in gVCF output block.">
##INFO=<ID=END,Number=1,Type=Integer,Description="Last position (inclusive) in gVCF output record.">
##INFO=<ID=calledBy,Number=A,Type=String,Description="Name of the tool which called the variant. If a variant is called by both tools, value is set as calledBy=freeBayes+freeBayes">
##FORMAT=<ID=GT,Number=1,Type=String,Description="Genotype">
##FORMAT=<ID=GQ,Number=1,Type=Float,Description="Genotype Quality, the Phred-scaled marginal (or unconditional) probability of the called genotype">
##FORMAT=<ID=GL,Number=G,Type=Float,Description="Genotype Likelihood, log10-scaled likelihoods of the data given the called genotype for each possible genotype generated from the reference and alternate alleles given the sample ploidy">
##FORMAT=<ID=DP,Number=1,Type=Integer,Description="Read Depth">
##FORMAT=<ID=AD,Number=R,Type=Integer,Description="Number of observation for each allele">
##FORMAT=<ID=RO,Number=1,Type=Integer,Description="Reference allele observation count">
##FORMAT=<ID=QR,Number=1,Type=Integer,Description="Sum of quality of the reference observations">
##FORMAT=<ID=AO,Number=A,Type=Integer,Description="Alternate allele observation count">
##FORMAT=<ID=QA,Number=A,Type=Integer,Description="Sum of quality of the alternate observations">
##FORMAT=<ID=MIN_DP,Number=1,Type=Integer,Description="Minimum depth in gVCF output block.">
#CHROM 	POS 	ID 	REF 	ALT 	QUAL 	FILTER 	INFO 	FORMAT 	SRR5997560 	SRR5997561 	SRR5997562 	SRR5997563 	SRR5997566 	
chr17 	 7668134 	 . 	 G 	 A 	 8154.7 	 . 	 AB=0.267176;ABP=188.05;AC=6;AF=0.6;AN=10;AO=342;CIGAR=1X;DP=1026;DPB=1026;DPRA=0.399367;EPP=13.1692;EPPR=3.09002;GTI=1;LEN=1;MEANALT=1.5;MQM=43.0088;MQMR=43.8517;NS=5;NUMALT=1;ODDS=30.4117;PAIRED=0.979532;PAIREDR=0.982379;PAO=0;PQA=0;PQR=0;PRO=0;QA=11659;QR=23142;RO=681;RPL=241;RPP=127.457;RPPR=81.6074;RPR=101;RUN=1;SAF=94;SAP=153.591;SAR=248;SRF=205;SRP=237.188;SRR=476;TYPE=snp;calledBy=freeBayes+freeBayes;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Benign 	 GT:DP:AD:RO:QR:AO:QA:GL:CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Benign 	 0/1:289:218,70:218:7485:70:2360:-121.898,0,-576.29 	 0/1:104:68,35:68:2221:35:1214:-73.8552,0,-164.596 	 1/1:92:1,91:1:32:91:3201:-280.192,-25.0401,0 	 0/0:395:394,0:394:13404:0:0:0,-118.606,-1187.45 	 1/1:146:0,146:0:0:146:4884:-431.366,-43.9504,0 	 
chr17 	 7668434 	 . 	 T 	 G 	 5351.69 	 . 	 AB=0.62465;ABP=51.1902;AC=1;AF=0.1;AN=10;AO=225;CIGAR=1X;DP=2090;DPB=2090;DPRA=1.21429;EPP=82.9301;EPPR=4.06214;GTI=0;LEN=1;MEANALT=1.5;MQM=43.4489;MQMR=43.6561;NS=5;NUMALT=1;ODDS=189.964;PAIRED=0.968889;PAIREDR=0.973628;PAO=0;PQA=0;PQR=0;PRO=0;QA=7572;QR=62921;RO=1858;RPL=97;RPP=12.2849;RPPR=122.687;RPR=128;RUN=1;SAF=74;SAP=60.231;SAR=151;SRF=821;SRP=57.5379;SRR=1037;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001624|3_prime_UTR_variant;RS=78378222;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_conflicting_interpretations;CLNSIG=Conflicting_interpretations_of_pathogenicity 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001624|3_prime_UTR_variant;RS=78378222;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_conflicting_interpretations;CLNSIG=Conflicting_interpretations_of_pathogenicity 	 0/0:578:574,2:574:19338:2:28:0,-170.891,-1706.83 	 0/0:178:177,0:177:5981:0:0:0,-53.2823,-528.117 	 0/0:183:181,0:181:6144:0:0:0,-54.4864,-540.739 	 0/0:794:792,0:792:26973:0:0:0,-238.416,-2386.52 	 0/1:357:134,223:134:4485:223:7544:-559.385,0,-289.601 	 
chr17 	 7668783 	 . 	 C 	 T 	 128.214 	 . 	 AB=0.764706;ABP=13.3567;AC=1;AF=0.1;AN=10;AO=18;CIGAR=1X;DP=285;DPB=285;DPRA=0.720195;EPP=10.7311;EPPR=299.705;GTI=0;LEN=1;MEANALT=1;MQM=42.1111;MQMR=43.6704;NS=5;NUMALT=1;ODDS=27.7262;PAIRED=1;PAIREDR=1;PAO=0;PQA=0;PQR=0;PRO=0;QA=541;QR=8817;RO=267;RPL=13;RPP=10.7311;RPPR=287.408;RPR=5;RUN=1;SAF=18;SAP=42.0968;SAR=0;SRF=265;SRP=565.552;SRR=2;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001624|3_prime_UTR_variant;RS=17884306;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001624|3_prime_UTR_variant;RS=17884306;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Benign 	 0/0:77:77,0:77:2517:0:0:0,-23.1793,-223.246 	 0/0:19:18,1:18:624:1:36:0,-2.98337,-52.7236 	 0/0:60:60,0:60:1997:0:0:0,-18.0618,-177.447 	 0/0:112:108,4:108:3579:4:103:0,-24.2863,-308.03 	 0/1:17:4,13:4:100:13:402:-30.8371,0,-4.01355 	 
chr17 	 7669911 	 . 	 C 	 T 	 777.515 	 . 	 AB=0.413043;ABP=12.0738;AC=1;AF=0.1;AN=10;AO=59;CIGAR=1X;DP=1392;DPB=1392;DPRA=0.359305;EPP=58.9901;EPPR=38.3176;GTI=0;LEN=1;MEANALT=1.5;MQM=43.0678;MQMR=43.6938;NS=5;NUMALT=1;ODDS=179.03;PAIRED=0.949153;PAIREDR=0.994733;PAO=0;PQA=0;PQR=0;PRO=0;QA=1978;QR=44934;RO=1329;RPL=57;RPP=114.344;RPPR=332.409;RPR=2;RUN=1;SAF=8;SAP=71.062;SAR=51;SRF=153;SRP=1712.95;SRR=1176;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001627|intron_variant;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001627|intron_variant;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Benign 	 0/0:438:438,0:438:14944:0:0:0,-131.851,-1322.84 	 0/0:131:127,2:127:4088:2:68:0,-32.7191,-352 	 0/0:160:160,0:160:5432:0:0:0,-48.1648,-480.921 	 0/0:525:523,0:523:17769:0:0:0,-157.439,-1573.42 	 0/1:138:81,57:81:2701:57:1910:-127.1,0,-197.51 	 
chr17 	 7670627 	 . 	 C 	 T 	 7.85929e-14 	 . 	 AB=0.128205;ABP=190.314;AC=1;AF=0.1;AN=10;AO=20;CIGAR=1X;DP=1305;DPB=1305;DPRA=0.543081;EPP=46.4397;EPPR=136.651;GTI=0;LEN=1;MEANALT=1;MQM=43.9;MQMR=43.781;NS=5;NUMALT=1;ODDS=99.0715;PAIRED=1;PAIREDR=0.993765;PAO=0;PQA=0;PQR=0;PRO=0;QA=672;QR=43621;RO=1283;RPL=20;RPP=46.4397;RPPR=129.15;RPR=0;RUN=1;SAF=20;SAP=46.4397;SAR=0;SRF=917;SRP=516.854;SRR=366;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001583|missense_variant,SO:0001624|3_prime_UTR_variant;RS=587781663;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Uncertain_significance 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001583|missense_variant,SO:0001624|3_prime_UTR_variant;RS=587781663;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Uncertain_significance 	 0/0:431:430,0:430:14714:0:0:0,-129.443,-1302.71 	 0/0:91:91,0:91:3097:0:0:0,-27.3937,-270.351 	 0/0:155:155,0:155:5211:0:0:0,-46.6596,-461.161 	 0/0:472:471,0:471:15876:0:0:0,-141.785,-1406.09 	 0/1:156:136,20:136:4723:20:672:-12.8476,0,-371.524 	 
chr17 	 7673183 	 . 	 G 	 A 	 3232.27 	 . 	 AB=0.768182;ABP=140.445;AC=1;AF=0.1;AN=10;AO=169;CIGAR=1X;DP=1605;DPB=1605;DPRA=0.635379;EPP=144.67;EPPR=521.769;GTI=0;LEN=1;MEANALT=3;MQM=42.5976;MQMR=42.3397;NS=5;NUMALT=1;ODDS=107.048;PAIRED=0.982249;PAIREDR=0.992647;PAO=0;PQA=0;PQR=0;PRO=0;QA=5377;QR=44508;RO=1360;RPL=31;RPP=150.118;RPPR=812.433;RPR=138;RUN=1;SAF=168;SAP=361.355;SAR=1;SRF=1283;SRP=2325.27;SRR=77;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001627|intron_variant;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001627|intron_variant;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Benign 	 0/0:435:410,0:410:13519:0:0:0,-123.422,-1180.05 	 0/0:89:88,0:88:2841:0:0:0,-26.4906,-244.477 	 0/0:205:195,0:195:6350:0:0:0,-58.7008,-556.584 	 0/0:656:626,0:626:20435:0:0:0,-188.445,-1789.13 	 0/1:220:41,169:41:1363:169:5377:-410.075,0,-55.9653 	 
chr17 	 7673606 	 . 	 G 	 A 	 2.9412e-14 	 . 	 AB=0;ABP=0;AC=0;AF=0;AN=10;AO=41;CIGAR=1X;DP=3851;DPB=3851;DPRA=2.69372;EPP=60.6867;EPPR=16.3766;GTI=0;LEN=1;MEANALT=2.33333;MQM=43.8537;MQMR=43.6269;NS=5;NUMALT=1;ODDS=333.87;PAIRED=1;PAIREDR=0.978438;PAO=0;PQA=0;PQR=0;PRO=0;QA=1381;QR=130443;RO=3803;RPL=17;RPP=5.60547;RPPR=49.3889;RPR=24;RUN=1;SAF=19;SAP=3.48696;SAR=22;SRF=1563;SRP=264.711;SRR=2240;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001819|synonymous_variant;RS=1555525016;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Likely_benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001819|synonymous_variant;RS=1555525016;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Likely_benign 	 0/0:1150:1145,3:1145:39102:3:108:0,-335.907,-3448.37 	 0/0:334:334,0:334:11448:0:0:0,-100.544,-998.507 	 0/0:430:430,0:430:14938:0:0:0,-129.443,-1320.76 	 0/0:1599:1589,5:1589:54574:5:180:0,-463.856,-4808.03 	 0/0:338:305,33:305:10381:33:1093:0,-4.62909,-804.743 	 
chr17 	 7674089 	 . 	 A 	 C 	 14658.4 	 . 	 AB=0.572254;ABP=50.0798;AC=2;AF=0.2;AN=10;AO=594;CIGAR=1X;DP=2459;DPB=2459;DPRA=1.09571;EPP=3.1419;EPPR=6.67934;GTI=0;LEN=1;MEANALT=2.5;MQM=43.7761;MQMR=43.5463;NS=5;NUMALT=1;ODDS=193.886;PAIRED=0.978114;PAIREDR=0.979526;PAO=0;PQA=0;PQR=0;PRO=0;QA=20377;QR=62402;RO=1856;RPL=341;RPP=31.3199;RPPR=37.6228;RPR=253;RUN=1;SAF=233;SAP=62.9049;SAR=361;SRF=862;SRP=23.3959;SRR=994;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001627|intron_variant;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001627|intron_variant;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Benign 	 0/1:747:245,500:245:8385:500:17113:-1289.43,0,-517.596 	 0/0:266:266,0:266:8971:0:0:0,-80.074,-781.439 	 0/1:291:196,94:196:6635:94:3264:-201.433,0,-499.807 	 0/0:878:874,0:874:29313:0:0:0,-263.1,-2593.84 	 0/0:277:275,0:275:9098:0:0:0,-82.7832,-800.069 	 
chr17 	 7674109 	 . 	 G 	 A 	 12308.7 	 . 	 AB=0.56969;ABP=41.1456;AC=2;AF=0.2;AN=10;AO=515;CIGAR=1X;DP=2109;DPB=2109;DPRA=1.12531;EPP=3.35183;EPPR=34.6431;GTI=0;LEN=1;MEANALT=2.5;MQM=43.7845;MQMR=43.6381;NS=5;NUMALT=1;ODDS=163.525;PAIRED=0.982524;PAIREDR=0.979823;PAO=0;PQA=0;PQR=0;PRO=0;QA=17211;QR=54257;RO=1586;RPL=286;RPP=16.7096;RPPR=3.4539;RPR=229;RUN=1;SAF=203;SAP=53.106;SAR=312;SRF=683;SRP=69.2772;SRR=903;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001627|intron_variant;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001627|intron_variant;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Benign 	 0/1:640:206,429:206:7150:429:14340:-1078.13,0,-441.857 	 0/0:246:246,0:246:8409:0:0:0,-74.0534,-738.292 	 0/1:264:177,86:177:5988:86:2871:-175.012,0,-450.407 	 0/0:731:729,0:729:24884:0:0:0,-219.451,-2201.77 	 0/0:228:228,0:228:7826:0:0:0,-68.6348,-685.278 	 
chr17 	 7674326 	 . 	 C 	 G 	 5.13507e-14 	 . 	 AB=0;ABP=0;AC=0;AF=0;AN=10;AO=73;CIGAR=1X;DP=1214;DPB=1214;DPRA=0;EPP=161.528;EPPR=35.4289;GTI=0;LEN=1;MEANALT=2;MQM=41.3014;MQMR=43.0406;NS=5;NUMALT=1;ODDS=166.624;PAIRED=1;PAIREDR=0.992049;PAO=0;PQA=0;PQR=0;PRO=0;QA=1182;QR=35408;RO=1132;RPL=0;RPP=161.528;RPPR=448.669;RPR=73;RUN=1;SAF=0;SAP=161.528;SAR=73;SRF=368;SRP=303.824;SRR=764;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001627|intron_variant;RS=17880604;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001627|intron_variant;RS=17880604;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Benign 	 0/0:357:340,17:340:10451:17:289:0,-81.3283,-899.067 	 0/0:144:136,7:136:4258:7:116:0,-32.6179,-360.912 	 0/0:127:115,11:115:3631:11:170:0,-22.6945,-304.792 	 0/0:458:417,36:417:13035:36:574:0,-84.8466,-1099.82 	 0/0:128:124,2:124:4033:2:33:0,-35.0373,-352.258 	 
chr17 	 7674390 	 . 	 G 	 A 	 0 	 . 	 AB=0;ABP=0;AC=0;AF=0;AN=10;AO=6;CIGAR=1X;DP=516;DPB=516;DPRA=0.933333;EPP=3.0103;EPPR=99.5679;GTI=0;LEN=1;MEANALT=1.33333;MQM=36.3333;MQMR=41.7332;NS=5;NUMALT=1;ODDS=60.284;PAIRED=1;PAIREDR=0.998024;PAO=0;PQA=0;PQR=0;PRO=0;QA=177;QR=15344;RO=506;RPL=3;RPP=3.0103;RPPR=195.885;RPR=3;RUN=1;SAF=0;SAP=16.0391;SAR=6;SRF=33;SRP=833.835;SRR=473;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001627|intron_variant;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Likely_benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001627|intron_variant;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Likely_benign 	 0/0:180:177,0:177:5337:0:0:0,-53.2823,-472.671 	 0/0:44:40,4:40:1174:4:113:0,-3.11017,-87.003 	 0/0:57:55,1:55:1701:1:28:0,-14.3245,-146.853 	 0/0:200:199,1:199:6152:1:36:0,-56.7253,-540.837 	 0/0:35:35,0:35:980:0:0:0,-10.536,-77.4254 	 
chr17 	 7674797 	 . 	 T 	 C 	 45504.8 	 . 	 AB=0;ABP=0;AC=10;AF=1;AN=10;AO=1535;CIGAR=1X;DP=1546;DPB=1546;DPRA=0;EPP=72.1027;EPPR=7.35324;GTI=0;LEN=1;MEANALT=2;MQM=43.7746;MQMR=44;NS=5;NUMALT=1;ODDS=253.095;PAIRED=0.989577;PAIREDR=1;PAO=0;PQA=0;PQR=0;PRO=0;QA=51659;QR=72;RO=2;RPL=679;RPP=47.3296;RPPR=7.35324;RPR=856;RUN=1;SAF=823;SAP=20.4401;SAR=712;SRF=2;SRP=7.35324;SRR=0;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001627|intron_variant;RS=1625895;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001627|intron_variant;RS=1625895;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Benign 	 1/1:448:0,447:0:0:447:15131:-1340.18,-134.56,0 	 1/1:155:0,154:0:0:154:5205:-460.044,-46.3586,0 	 1/1:160:2,158:2:72:158:5426:-473.715,-41.4462,0 	 1/1:660:0,654:0:0:654:21828:-1932.61,-196.874,0 	 1/1:123:0,122:0:0:122:4069:-360.307,-36.7257,0 	 
chr17 	 7675327 	 . 	 C 	 T 	 90546.6 	 . 	 AB=0;ABP=0;AC=10;AF=1;AN=10;AO=3094;CIGAR=1X;DP=3135;DPB=3135;DPRA=0;EPP=240.738;EPPR=3.25157;GTI=0;LEN=1;MEANALT=2.8;MQM=43.2262;MQMR=43.3333;NS=5;NUMALT=1;ODDS=461.225;PAIRED=0.973497;PAIREDR=1;PAO=0;PQA=0;PQR=0;PRO=0;QA=103587;QR=254;RO=9;RPL=1533;RPP=3.56054;RPPR=22.5536;RPR=1561;RUN=1;SAF=1303;SAP=170.148;SAR=1791;SRF=4;SRP=3.25157;SRR=5;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001627|intron_variant;RS=2909430;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001627|intron_variant;RS=2909430;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Benign 	 1/1:921:0,910:0:0:910:30721:-2708.1,-273.937,0 	 1/1:299:1,296:1:14:296:9829:-857.688,-88.1749,0 	 1/1:396:2,389:2:72:389:12974:-1131.71,-111.378,0 	 1/1:1258:1,1247:1:14:1247:41958:-3700.81,-374.426,0 	 1/1:261:5,252:5:154:252:8105:-698.697,-63.6395,0 	 
chr17 	 7675353 	 . 	 C 	 T 	 1157.92 	 . 	 AB=0.395556;ABP=24.3293;AC=1;AF=0.1;AN=10;AO=93;CIGAR=1X;DP=2884;DPB=2884;DPRA=0.633311;EPP=34.9753;EPPR=3.81478;GTI=0;LEN=1;MEANALT=2.66667;MQM=41.5699;MQMR=42.9323;NS=5;NUMALT=1;ODDS=266.621;PAIRED=0.967742;PAIREDR=0.972504;PAO=0;PQA=0;PQR=0;PRO=0;QA=2897;QR=89450;RO=2764;RPL=67;RPP=42.2602;RPPR=155.108;RPR=26;RUN=1;SAF=30;SAP=28.4375;SAR=63;SRF=1024;SRP=405.767;SRR=1740;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001627|intron_variant;RS=35850753;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Likely_benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001627|intron_variant;RS=35850753;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Likely_benign 	 0/0:878:872,2:872:28090:2:50:0,-258.646,-2472.07 	 0/0:302:299,2:299:9892:2:50:0,-86.2379,-852.437 	 0/0:333:328,0:328:10568:0:0:0,-98.7378,-933.021 	 0/0:1146:1132,0:1132:36738:0:0:0,-340.766,-3243.46 	 0/1:225:133,89:133:4162:89:2797:-175.545,0,-293.887 	 
chr17 	 7675361 	 . 	 A 	 G 	 844.778 	 . 	 AB=0.352113;ABP=43.4731;AC=1;AF=0.1;AN=10;AO=77;CIGAR=1X;DP=2653;DPB=2653;DPRA=0.926524;EPP=33.7211;EPPR=107.669;GTI=0;LEN=1;MEANALT=3;MQM=40.5455;MQMR=42.7685;NS=5;NUMALT=1;ODDS=194.517;PAIRED=0.961039;PAIREDR=0.970504;PAO=0;PQA=0;PQR=0;PRO=0;QA=2436;QR=77066;RO=2441;RPL=59;RPP=50.4161;RPPR=721.972;RPR=18;RUN=1;SAF=26;SAP=20.6359;SAR=51;SRF=890;SRP=391.688;SRR=1551;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001627|intron_variant;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001627|intron_variant;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Benign 	 0/0:800:750,2:750:23327:2:45:0,-222.594,-2054.06 	 0/0:281:272,0:272:8877:0:0:0,-81.8802,-757.588 	 0/0:320:293,0:293:9408:0:0:0,-88.2018,-829.084 	 0/0:1039:992,0:992:31275:0:0:0,-298.622,-2756.29 	 0/1:213:134,75:134:4179:75:2391:-142.841,0,-294.403 	 
chr17 	 7675519 	 . 	 A 	 G 	 2764.89 	 . 	 AB=0;ABP=0;AC=10;AF=1;AN=10;AO=105;CIGAR=1X;DP=106;DPB=106;DPRA=0;EPP=56.8008;EPPR=5.18177;GTI=0;LEN=1;MEANALT=1;MQM=42.6762;MQMR=44;NS=5;NUMALT=1;ODDS=21.331;PAIRED=1;PAIREDR=1;PAO=0;PQA=0;PQR=0;PRO=0;QA=3591;QR=36;RO=1;RPL=76;RPP=48.6939;RPPR=5.18177;RPR=29;RUN=1;SAF=4;SAP=197.595;SAR=101;SRF=0;SRP=5.18177;SRR=1;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001627|intron_variant;RS=1794287;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001627|intron_variant;RS=1794287;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Benign 	 1/1:46:0,46:0:0:46:1548:-136.809,-13.8474,0 	 1/1:8:0,8:0:0:8:284:-25.1027,-2.40824,0 	 1/1:9:0,9:0:0:9:296:-26.5508,-2.70927,0 	 1/1:38:1,37:1:36:37:1287:-109.256,-7.90302,0 	 1/1:5:0,5:0:0:5:176:-15.2579,-1.50515,0 	 
chr17 	 7676120 	 . 	 C 	 T 	 0 	 . 	 AB=0;ABP=0;AC=0;AF=0;AN=10;AO=5;CIGAR=1X;DP=854;DPB=854;DPRA=0.447917;EPP=13.8677;EPPR=16.4434;GTI=0;LEN=1;MEANALT=2;MQM=42.4;MQMR=43.6038;NS=5;NUMALT=1;ODDS=113.678;PAIRED=1;PAIREDR=0.995227;PAO=0;PQA=0;PQR=0;PRO=0;QA=159;QR=27381;RO=838;RPL=0;RPP=13.8677;RPPR=8.02697;RPR=5;RUN=1;SAF=5;SAP=13.8677;SAR=0;SRF=478;SRP=39.0909;SRR=360;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001819|synonymous_variant;RS=55754907;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Likely_benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001819|synonymous_variant;RS=55754907;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Likely_benign 	 0/0:304:299,0:299:9614:0:0:0,-90.008,-849.117 	 0/0:81:81,0:81:2593:0:0:0,-24.3834,-227.99 	 0/0:89:89,0:89:2921:0:0:0,-26.7917,-256.046 	 0/0:294:290,0:290:9636:0:0:0,-87.2987,-853.387 	 0/0:86:79,5:79:2617:5:159:0,-11.1,-217.134 	 
chr17 	 7676154 	 . 	 G 	 C 	 17165.4 	 . 	 AB=0.336384;ABP=104.622;AC=8;AF=0.8;AN=10;AO=659;CIGAR=1X;DP=955;DPB=955;DPRA=0;EPP=3.2772;EPPR=10.5735;GTI=0;LEN=1;MEANALT=1.4;MQM=43.5099;MQMR=43.3469;NS=5;NUMALT=1;ODDS=31.3149;PAIRED=0.986343;PAIREDR=0.993197;PAO=0;PQA=0;PQR=0;PRO=0;QA=21434;QR=9764;RO=294;RPL=282;RPP=32.7486;RPPR=13.6756;RPR=377;RUN=1;SAF=390;SAP=51.2539;SAR=269;SRF=167;SRP=14.8278;SRR=127;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001583|missense_variant;RS=1042522;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001583|missense_variant;RS=1042522;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Benign 	 0/1:342:242,99:242:8096:99:3275:-180.346,0,-611.061 	 1/1:94:1,93:1:32:93:2844:-249.166,-25.1234,0 	 1/1:101:1,100:1:14:100:3284:-283.872,-29.0044,0 	 1/1:323:3,319:3:42:319:10483:-925.429,-93.2397,0 	 0/1:95:47,48:47:1580:48:1548:-108.456,0,-110.624 	 
chr17 	 7676225 	 . 	 G 	 A 	 8.9205e-15 	 . 	 AB=0;ABP=0;AC=0;AF=0;AN=10;AO=7;CIGAR=1X;DP=1343;DPB=1343;DPRA=1.03396;EPP=3.32051;EPPR=35.4942;GTI=0;LEN=1;MEANALT=2;MQM=44;MQMR=43.0519;NS=5;NUMALT=1;ODDS=153.01;PAIRED=1;PAIREDR=0.974417;PAO=0;PQA=0;PQR=0;PRO=0;QA=248;QR=45270;RO=1329;RPL=5;RPP=5.80219;RPPR=3.09036;RPR=2;RUN=1;SAF=5;SAP=5.80219;SAR=2;SRF=597;SRP=32.7884;SRR=732;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001819|synonymous_variant;RS=587781460;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Likely_benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001819|synonymous_variant;RS=587781460;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Likely_benign 	 0/0:449:446,1:446:15163:1:36:0,-131.307,-1327.82 	 0/0:140:138,0:138:4711:0:0:0,-41.5421,-411.62 	 0/0:137:135,0:135:4586:0:0:0,-40.639,-397.214 	 0/0:518:517,0:517:17647:0:0:0,-155.633,-1531.92 	 0/0:99:93,6:93:3163:6:212:0,-10.6857,-258.895 	 
chr17 	 7676301 	 . 	 G 	 T 	 224.979 	 . 	 AB=0.488372;ABP=3.0608;AC=1;AF=0.1;AN=10;AO=22;CIGAR=1X;DP=597;DPB=597;DPRA=0.365625;EPP=6.56362;EPPR=172.32;GTI=0;LEN=1;MEANALT=1;MQM=37.5909;MQMR=42.1699;NS=5;NUMALT=1;ODDS=51.8034;PAIRED=0.909091;PAIREDR=0.989492;PAO=0;PQA=0;PQR=0;PRO=0;QA=677;QR=19461;RO=571;RPL=8;RPP=6.56362;RPPR=165.962;RPR=14;RUN=1;SAF=6;SAP=12.8806;SAR=16;SRF=162;SRP=235.023;SRR=409;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001627|intron_variant;RS=17883323;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001627|intron_variant;RS=17883323;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Benign 	 0/0:187:186,0:186:6306:0:0:0,-55.9916,-535.683 	 0/0:61:61,0:61:2134:0:0:0,-18.3628,-181.214 	 0/0:74:73,1:73:2486:1:21:0,-20.1796,-217.545 	 0/0:232:229,0:229:7759:0:0:0,-68.9359,-669.727 	 0/1:43:22,21:22:776:21:656:-38.3245,0,-56.0821 	 
chr17 	 7676443 	 . 	 C 	 T 	 0 	 . 	 AB=0;ABP=0;AC=0;AF=0;AN=10;AO=8;CIGAR=1X;DP=668;DPB=668;DPRA=1.41279;EPP=20.3821;EPPR=15.8127;GTI=0;LEN=1;MEANALT=1.5;MQM=44;MQMR=40.862;NS=5;NUMALT=1;ODDS=76.7941;PAIRED=1;PAIREDR=0.930982;PAO=0;PQA=0;PQR=0;PRO=0;QA=288;QR=21917;RO=652;RPL=1;RPP=12.7819;RPPR=133.578;RPR=7;RUN=1;SAF=7;SAP=12.7819;SAR=1;SRF=374;SRP=33.704;SRR=278;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001623|5_prime_UTR_variant,SO:0001627|intron_variant;RS=372756865;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Likely_benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001623|5_prime_UTR_variant,SO:0001627|intron_variant;RS=372756865;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Likely_benign 	 0/0:217:214,0:214:7263:0:0:0,-64.4204,-618.629 	 0/0:55:53,0:53:1744:0:0:0,-15.9546,-146.428 	 0/0:72:72,0:72:2445:0:0:0,-21.6742,-211.704 	 0/0:238:234,1:234:7745:1:36:0,-67.5086,-659.112 	 0/0:86:79,7:79:2720:7:252:0,-3.25739,-197.808 	 
chr17 	 7676483 	 . 	 G 	 C 	 6721.32 	 . 	 AB=0.501603;ABP=3.02422;AC=5;AF=0.5;AN=10;AO=313;CIGAR=1X;DP=624;DPB=624;DPRA=0;EPP=42.0344;EPPR=57.6073;GTI=0;LEN=1;MEANALT=1.4;MQM=42.6518;MQMR=41.4221;NS=5;NUMALT=1;ODDS=42.4037;PAIRED=0.980831;PAIREDR=0.99026;PAO=0;PQA=0;PQR=0;PRO=0;QA=10486;QR=9106;RO=308;RPL=129;RPP=23.9966;RPPR=149.204;RPR=184;RUN=1;SAF=275;SAP=392.689;SAR=38;SRF=140;SRP=8.53768;SRR=168;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001623|5_prime_UTR_variant,SO:0001627|intron_variant;RS=1642785;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001623|5_prime_UTR_variant,SO:0001627|intron_variant;RS=1642785;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;CLNSIG=Benign 	 0/1:217:174,41:174:5655:41:1370:-56.1809,0,-427.562 	 0/1:60:18,41:18:408:41:1390:-105.045,0,-18.1585 	 0/1:72:21,51:21:519:51:1741:-129.896,0,-24.1848 	 0/1:212:52,160:52:1241:160:5307:-400.567,0,-42.6009 	 0/1:63:43,20:43:1283:20:678:-40.9272,0,-93.2969 	 
chr17 	 7676734 	 . 	 C 	 T 	 1205.37 	 . 	 AB=0.5;ABP=3.0103;AC=1;AF=0.1;AN=10;AO=59;CIGAR=1X;DP=1245;DPB=1245;DPRA=1.06878;EPP=3.0471;EPPR=5.13401;GTI=0;LEN=1;MEANALT=2;MQM=43.7966;MQMR=43.599;NS=5;NUMALT=1;ODDS=171.34;PAIRED=1;PAIREDR=0.980541;PAO=0;PQA=0;PQR=0;PRO=0;QA=1990;QR=39791;RO=1182;RPL=31;RPP=3.34154;RPPR=3.4806;RPR=28;RUN=1;SAF=25;SAP=5.99147;SAR=34;SRF=557;SRP=11.5051;SRR=625;TYPE=snp;calledBy=freeBayes+freeBayes;MC=SO:0001627|intron_variant;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Benign 	 GT:DP:AD:RO:QR:AO:QA:GL:MC=SO:0001627|intron_variant;CLNVC=single_nucleotide_variant;CLNVCSO=SO:0001483;CLNREVSTAT=criteria_provided,_single_submitter;CLNSIG=Benign 	 0/0:402:400,1:400:13513:1:36:0,-117.424,-1192.33 	 0/0:100:100,0:100:3302:0:0:0,-30.103,-286.648 	 0/0:144:144,0:144:4845:0:0:0,-43.3483,-429.386 	 0/0:483:481,0:481:16185:0:0:0,-144.795,-1432.59 	 0/1:116:57,58:57:1946:58:1954:-138.462,0,-136.582 	 
